UNITED GUARDIAN INC - 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2009, and the nine-month period ended on the same date. United-Guardian, Inc. is a Delaware corporation engaged in the research, development, manufacturing, and marketing of cosmetic ingredients, personal care products, pharmaceuticals, and specialty industrial products. The company is classified as a smaller reporting company.
Key Financial Metrics
| Metric | Nine Months Ended Sep 30, 2009 | Nine Months Ended Sep 30, 2008 | Three Months Ended Sep 30, 2009 | Three Months Ended Sep 30, 2008 |
|---|---|---|---|---|
| Net Sales | $10,281,426 | $9,500,563 | $3,393,139 | $3,498,325 |
| Net Income | $2,992,420 | $2,487,057 | $1,081,748 | $911,494 |
| Earnings Per Share (Basic/Diluted) | $0.60 | $0.50 | $0.22 | $0.18 |
| Operating Cash Flow | $3,218,554 | $2,494,954 | N/A | N/A |
| Cash and Equivalents (Sep 30, 2009) | $2,194,680 | $3,425,538 (Dec 31, 2008) | N/A | N/A |
| Working Capital | $15,451,846 | $13,236,680 (Dec 31, 2008) | N/A | N/A |
| Current Ratio | 13.0 to 1 | 6.2 to 1 (Dec 31, 2008) | N/A | N/A |
| Long-Term Debt | $0 | $0 | N/A | N/A |
Margins: Cost of sales as a percentage of net sales decreased to 40.2% for the nine months ended September 30, 2009, compared to 43.9% in the prior year period. The effective income tax rate was approximately 33.0% for all periods presented.
Material Changes vs. Prior Period
- Revenue: Net sales increased 8.2% for the nine-month period but decreased 3.0% for the three-month period compared to 2008.
- Pharmaceuticals: Sales increased 16.4% year-to-date due to a price increase in May 2009 that accelerated customer inventory purchases in Q2. Q3 sales decreased 14.5% as the effect of the price increase normalized.
- Personal Care: Sales decreased 1.7% year-to-date, attributed to customer ordering patterns rather than a decline in product usage.
- Medical Products: Sales increased 41.7% year-to-date, driven by a new customer acquisition following a product line sale to a multinational pharmaceutical company.
- Expenses: Operating expenses decreased 2.1% (nine months) and 14.0% (three months) primarily due to reductions in payroll and payroll-related expenses.
- Investment Income: Decreased 24.3% year-to-date due to lower interest rates and investment returns.
- Liquidity: Working capital increased by $2.2 million. The current ratio improved significantly from 6.2 to 1 to 13.0 to 1, largely due to the payment of dividends payable ($1.38 million) from the prior year.
Outlook, Risks, and Management Commentary
- Outlook: Management anticipates pharmaceutical sales volume for the full year 2009 will be comparable to 2008. The company believes its working capital is sufficient to support operations for at least the next twelve months and does not expect significant capital expenditures for the remainder of 2009.
- Pension Plan: The company is in the process of terminating its defined benefit pension plan (frozen since 2007) and expects regulatory approval in late 2009 or early 2010. Upon termination, non-vested benefits will become fully vested.
- Risks: Forward-looking statements are subject to risks including product development competition, market acceptance, economic conditions, and changes in interest rates. The company notes that results may differ materially from expectations.
- Unusual Items: A change in control occurred on April 9, 2009, due to the death of the company's largest stockholder. The company also discharged its certifying accountant and engaged a new one in July 2009.
Key Facts for Investor Verification
- Dividend Payouts: The company paid approximately $2.77 million in dividends during the nine months ended September 30, 2009, which significantly impacted cash flow from financing activities.
- Customer Concentration: Approximately half of personal care products are sold outside the U.S. through five marketing partners, with International Specialty Products Inc. (ISP) being the largest volume purchaser.
- Inventory Valuation: The company maintains a reserve of $39,000 for slow-moving and obsolete inventory as of September 30, 2009.
- Investment Portfolio: The company holds significant marketable securities ($8.2 million) and certificates of deposit ($3.1 million), which generated investment income but are subject to market risk and interest rate fluctuations.
- Related Party Transactions: The company paid consulting fees to a former officer/director and accounting fees to a firm where a partner is a current director.